ANTIBODIES

Contributor Information
- Name Patrick Loll
- Institute Drexel University
Tool Details
- Tool name: Anti-Human Ataxin-3 [4B8]
- Alternate names: Machado-Joseph Disease (MJD) Protein 1; Spinocerebellar Ataxia Type 3
- Tool type: Antibodies
- Tool sub-type: Primary Antibody
- Class: Monoclonal
- Conjugate: Unconjugated
- Reactivity: Human
- Host: Mouse
- Molecular weight of the target: 42 kDa
- Cell signalling pathway: PI3K signalling
- Application: ELISA ; IP
- Description: Ataxin-3 is a deubiquitinating enzyme involved in the clearance of misfolded proteins. The enzyme functions in proteasome degradation and autophagy. Mutated forms of Ataxin-3 can lead to misfolded protein aggregation which cause the neurodegenerative disorder spinocerebellar ataxia type-3 (SCA3), also known as Machado-Joseph disease.
- Immunogen: Recombinant Human Ataxin-3
- Immunogen UniProt ID: ATX3_HUMAN
- Research area: Neurobiology; Biochemistry
- For Research Use Only
Target Details
- Target: Ataxin-3
- Target molecular weight: 42 kDa
- Target background: Ataxin-3 is a deubiquitinating enzyme involved in the clearance of misfolded proteins. The enzyme functions in proteasome degradation and autophagy. Mutated forms of Ataxin-3 can lead to misfolded protein aggregation which cause the neurodegenerative disorder spinocerebellar ataxia type-3 (SCA3), also known as Machado-Joseph disease.
Application Details
- Application: ELISA ; IP
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15ðC to -25ðC
- Shipping conditions: Shipping at 4ðC